GE HealthCare Technologies Inc. $GEHC Shares Bought by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP increased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 8.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,362,717 shares of the company’s stock after acquiring an additional 438,439 shares during the quarter. Dimensional Fund Advisors LP’s holdings in GE HealthCare Technologies were worth $402,647,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in GEHC. Empowered Funds LLC increased its holdings in shares of GE HealthCare Technologies by 6.1% in the first quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock valued at $2,328,000 after purchasing an additional 1,665 shares during the period. Acadian Asset Management LLC purchased a new position in GE HealthCare Technologies in the first quarter valued at about $259,000. Assetmark Inc. increased its stake in GE HealthCare Technologies by 46.0% in the 2nd quarter. Assetmark Inc. now owns 9,107 shares of the company’s stock valued at $675,000 after purchasing an additional 2,868 shares in the last quarter. Sigma Planning Corp increased its position in shares of GE HealthCare Technologies by 17.9% in the second quarter. Sigma Planning Corp now owns 7,057 shares of the company’s stock valued at $523,000 after buying an additional 1,071 shares in the last quarter. Finally, Key Financial Inc increased its holdings in GE HealthCare Technologies by 34.2% during the 2nd quarter. Key Financial Inc now owns 1,252 shares of the company’s stock valued at $93,000 after acquiring an additional 319 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. Piper Sandler boosted their price target on GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a report on Friday, January 30th. Bank of America upped their price target on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research report on Monday, January 5th. Wells Fargo & Company raised their price objective on GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Evercore raised their target price on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th. Finally, Morgan Stanley boosted their price target on GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 4th. Seven research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $92.50.

GE HealthCare Technologies Trading Up 1.1%

NASDAQ:GEHC opened at $79.02 on Thursday. The business’s 50 day moving average is $82.12 and its two-hundred day moving average is $78.54. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $89.77. The company has a market cap of $36.01 billion, a PE ratio of 17.33, a P/E/G ratio of 1.72 and a beta of 1.03. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. During the same quarter in the previous year, the firm earned $1.45 earnings per share. The firm’s revenue for the quarter was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be given a dividend of $0.035 per share. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 3.07%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.